(19)
(11) EP 1 212 305 A2

(12)

(88) Date of publication A3:
01.03.2001

(43) Date of publication:
12.06.2002 Bulletin 2002/24

(21) Application number: 00929488.5

(22) Date of filing: 04.05.2000
(51) International Patent Classification (IPC)7C07D 243/12, A61K 31/551, A61P 43/00
(86) International application number:
PCT/EP0003/982
(87) International publication number:
WO 0068/209 (16.11.2000 Gazette 2000/46)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 06.05.1999 GB 9910366
05.04.2000 GB 0008179

(71) Applicant: GLAXO GROUP LIMITED
Greenford, Middlesex UB6 ONN (GB)

(72) Inventors:
  • COLCLOUGH, David
    Kent DA1 5AH (GB)
  • HODGSON, Anne
    Kent DA1 5AH (GB)
  • SZEWCZYK, Jerzy, Ryszard
    Kent DA1 5AH (US)

(74) Representative: Giddings, Peter John, Dr. et al
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford,Middlesex TW8 9GS
Brentford,Middlesex TW8 9GS (GB)

   


(54) 1,5-BENZODIAZEPINE DERIVATIVES AS CCK-A RECEPTOR AGONISTS